TRIAMCINOLONE ACETONIDE INJECTABLE SUSPE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F9245 to DMS Pharmaceutical Group Inc on August 28, 2026, for the procurement of Triamcinolone Acetonide Injectable Suspe. This delivery order was issued under the base administrative contract SPE2DX25D9900, which was established by the DLA Troop Support Medical Supply Chain FSB on April 2, 2025, to replace a previous agreement. The order specifies the delivery of 2,300 units of the injectable suspension, identified by NSN 6505012104472, with a required delivery date of September 14, 2026, for shipment to Fort Bragg, North Carolina. While the total contract price is listed as 68.74, the order details indicate a unit price of 34.37.
General Info
Agency
Contract Value
$68.74NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
